HUTCHMED (CHINA) LIMITED_2025-06-302025-06-300001648257--12-312025Q2false00016482572025-01-012025-06-300001648257us-gaap:CommonStockMemberus-gaap:SubsequentEventMember2025-07-252025-07-250001648257us-gaap:CommonStockMember2025-01-012025-06-300001648257us-gaap:CommonStockMember2024-01-012024-06-300001648257hcm:MirageneMemberus-gaap:SubsequentEventMember2025-07-252025-07-250001648257hcm:InmageneBiopharmaceuticalsMemberus-gaap:SubsequentEventMember2025-07-252025-07-250001648257us-gaap:RetainedEarningsMember2025-06-300001648257us-gaap:ParentMember2025-06-300001648257us-gaap:NoncontrollingInterestMember2025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001648257us-gaap:RetainedEarningsMember2024-12-310001648257us-gaap:ParentMember2024-12-310001648257us-gaap:NoncontrollingInterestMember2024-12-310001648257us-gaap:AdditionalPaidInCapitalMember2024-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001648257us-gaap:RetainedEarningsMember2024-06-300001648257us-gaap:ParentMember2024-06-300001648257us-gaap:NoncontrollingInterestMember2024-06-300001648257us-gaap:AdditionalPaidInCapitalMember2024-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001648257us-gaap:RetainedEarningsMember2023-12-310001648257us-gaap:ParentMember2023-12-310001648257us-gaap:NoncontrollingInterestMember2023-12-310001648257us-gaap:AdditionalPaidInCapitalMember2023-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001648257hcm:HCMLShareOptionSchemeMember2023-01-012023-12-310001648257hcm:HCMLShareOptionSchemeMember2023-12-310001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2024-08-012024-08-310001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2024-03-012024-03-310001648257hcm:HCMLShareOptionSchemeMember2024-01-012024-12-310001648257hcm:HCMLShareOptionSchemeMember2024-12-310001648257srt:MaximumMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMember2023-12-310001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2025-06-012025-06-300001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2024-01-012024-12-310001648257us-gaap:OtherNoncurrentLiabilitiesMember2025-06-300001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2025-06-300001648257us-gaap:OtherNoncurrentLiabilitiesMember2024-12-310001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2024-12-310001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257us-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMember2025-01-012025-06-300001648257hcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2025-01-012025-06-300001648257hcm:GoodsDistributionMember2025-01-012025-06-300001648257hcm:CustomerMember2025-01-012025-06-300001648257hcm:CustomerBMember2025-01-012025-06-300001648257hcm:CommercializationServicesMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2025-01-012025-06-300001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2024-01-012024-06-300001648257us-gaap:RelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2024-01-012024-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:ResearchAndDevelopmentServicesMemberus-gaap:RelatedPartyMember2024-01-012024-06-300001648257hcm:ResearchAndDevelopmentServicesMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:RelatedPartyMember2024-01-012024-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2024-01-012024-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMembersrt:AffiliatedEntityMember2024-01-012024-06-300001648257hcm:RelatedPartyTransactionResearchAndDevelopmentServicesMemberus-gaap:EquityMethodInvesteeMember2024-01-012024-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2024-01-012024-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2024-01-012024-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2024-01-012024-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257us-gaap:RelatedPartyMember2024-01-012024-06-300001648257us-gaap:NonrelatedPartyMember2024-01-012024-06-300001648257hcm:ResearchAndDevelopmentServicesMember2024-01-012024-06-300001648257hcm:OtherVenturesSegmentMember2024-01-012024-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2024-01-012024-06-300001648257hcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:MarketedProductsMember2024-01-012024-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2024-01-012024-06-300001648257hcm:GoodsDistributionMember2024-01-012024-06-300001648257hcm:CustomerMember2024-01-012024-06-300001648257hcm:CustomerBMember2024-01-012024-06-300001648257hcm:CommercializationServicesMember2024-01-012024-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2024-01-012024-06-300001648257hcm:CollaborativeArrangementsMember2025-01-012025-06-300001648257hcm:CollaborativeArrangementsMember2024-01-012024-06-300001648257us-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257us-gaap:EquityMethodInvesteeMember2024-01-012024-06-300001648257us-gaap:RetainedEarningsMember2024-01-012024-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2025-01-012025-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2024-01-012024-06-300001648257us-gaap:CapitalAdditionsMember2025-01-012025-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2024-10-310001648257hcm:FixedAssetLoanFacilityMember2021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2025-06-300001648257hcm:FixedAssetLoanFacilityMember2025-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2024-12-310001648257hcm:FixedAssetLoanFacilityMember2024-12-310001648257hcm:FixedAssetLoanFacilityMember2025-01-012025-06-300001648257hcm:FixedAssetLoanFacilityMember2024-01-012024-12-310001648257hcm:HCMLShareOptionSchemeMember2025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-01-012025-06-300001648257hcm:CorporateAndReconcilingItemsMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2024-01-012024-06-300001648257hcm:CorporateAndReconcilingItemsMember2024-01-012024-06-300001648257hcm:LongTermIncentivePlanMember2025-06-300001648257hcm:LongTermIncentivePlanMember2024-12-310001648257hcm:FixedAssetLoanFacilityMember2021-10-012021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMemberhcm:OneYearChinaLoanPrimeRateMember2024-10-012024-10-310001648257hcm:FixedAssetLoanFacilityMemberhcm:FiveYearChinaLoanPrimeRateMember2021-10-012021-10-310001648257hcm:UnitedStatesAndOthersMember2025-01-012025-06-300001648257country:HK2025-01-012025-06-300001648257country:CN2025-01-012025-06-300001648257hcm:UnitedStatesAndOthersMember2024-01-012024-06-300001648257country:HK2024-01-012024-06-300001648257country:CN2024-01-012024-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2024-01-012024-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2024-01-012024-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2024-01-012024-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2024-01-012024-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2024-01-012024-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2024-01-012024-06-300001648257hcm:OtherVenturesSegmentMember2025-06-300001648257hcm:OncologyOrImmunologySegmentMember2025-06-300001648257hcm:OtherVenturesSegmentMember2024-12-310001648257hcm:OncologyOrImmunologySegmentMember2024-12-3100016482572025-01-010001648257us-gaap:CommonStockMember2025-06-300001648257us-gaap:CommonStockMember2024-12-310001648257us-gaap:CommonStockMember2024-06-300001648257us-gaap:CommonStockMember2023-12-310001648257srt:OtherCurrencyMember2025-06-300001648257currency:USD2025-06-300001648257currency:HKD2025-06-300001648257currency:GBP2025-06-300001648257currency:CNY2025-06-300001648257srt:OtherCurrencyMember2024-12-310001648257currency:USD2024-12-310001648257currency:HKD2024-12-310001648257currency:GBP2024-12-310001648257currency:CNY2024-12-310001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2024-12-310001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2023-12-310001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2024-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-06-300001648257hcm:UnitedStatesAndOthersMember2025-06-300001648257hcm:CorporateAndReconcilingItemsMember2025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2024-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2024-12-310001648257hcm:UnitedStatesAndOthersMember2024-12-310001648257hcm:CorporateAndReconcilingItemsMember2024-12-3100016482572024-06-3000016482572023-12-310001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2024-01-012024-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2024-01-012024-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2024-01-012024-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2024-01-012024-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2024-01-012024-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2024-01-012024-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2024-01-012024-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001648257hcm:HCMLShareOptionSchemeMember2024-01-012024-06-300001648257us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001648257us-gaap:NoncontrollingInterestMember2024-01-012024-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2025-06-300001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2025-06-300001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2025-06-300001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2025-06-300001648257us-gaap:NonrelatedPartyMember2025-06-300001648257hcm:SeroquelMember2025-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2024-12-310001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2024-12-310001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2024-12-310001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2024-12-310001648257us-gaap:NonrelatedPartyMember2024-12-310001648257us-gaap:ParentMember2024-01-012024-06-300001648257us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001648257us-gaap:RetainedEarningsMember2025-01-012025-06-300001648257srt:MinimumMember2025-01-012025-06-300001648257srt:MaximumMember2025-01-012025-06-300001648257srt:MinimumMember2024-01-012024-12-310001648257srt:MaximumMember2024-01-012024-12-310001648257hcm:LongTermIncentivePlanMember2024-01-012024-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareNotVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-03-132024-03-130001648257hcm:August52024TwoMemberhcm:OrdinarySharesOrAmericanDepositaryShareNotVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-08-052024-08-050001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2025-06-300001648257hcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2025-06-092025-06-090001648257hcm:August52024OneMemberhcm:OrdinarySharesOrAmericanDepositaryShareVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-08-052024-08-050001648257hcm:OrdinarySharesOrAmericanDepositaryShareVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2025-06-090001648257hcm:August52024TwoMemberhcm:OrdinarySharesOrAmericanDepositaryShareNotVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-08-050001648257hcm:August52024OneMemberhcm:OrdinarySharesOrAmericanDepositaryShareVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-08-050001648257hcm:OrdinarySharesOrAmericanDepositaryShareNotVestingBasedOnPerformanceMemberhcm:LongTermIncentivePlanMember2024-03-130001648257hcm:LongTermIncentivePlanMember2024-01-012024-12-310001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2024-01-012024-06-300001648257hcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMemberus-gaap:OtherNoncurrentLiabilitiesMember2025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMemberhcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2025-06-3000016482572024-01-012024-12-310001648257srt:AffiliatedEntityMember2025-01-012025-06-300001648257us-gaap:RelatedPartyMember2025-06-300001648257us-gaap:EquityMethodInvesteeMember2025-06-300001648257srt:AffiliatedEntityMember2025-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-06-300001648257us-gaap:RelatedPartyMember2024-12-310001648257us-gaap:EquityMethodInvesteeMember2024-12-310001648257srt:AffiliatedEntityMember2024-12-310001648257hcm:NonControllingShareholdersOfSubsidiariesMember2024-12-3100016482572025-06-2700016482572022-06-2700016482572021-10-212021-10-210001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-06-300001648257country:CN2025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2024-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2024-12-310001648257country:CN2024-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ParentCompanyOfCoVenturerMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2024-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2024-01-012024-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2025-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2024-12-310001648257us-gaap:ParentMember2025-01-012025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-01-012025-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2024-01-012024-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2024-01-012024-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-06-3000016482572024-01-012024-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-06-3000016482572025-06-3000016482572024-12-31iso4217:USDiso4217:CNYxbrli:purehcm:itemxbrli:sharesiso4217:USDxbrli:shareshcm:claim
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of August 2025
Commission File Number: 001-37710
HUTCHMED (CHINA) LIMITED
(Translation of registrant’s name into English)
48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ⌧ Form 40-F ☐
HUTCHMED (CHINA) LIMITED
Form 6-K
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HUTCHMED (CHINA) LIMITED |
| | |
| | |
| By: | /s/ JOHNNY CHENG |
| | Name: | Johnny Cheng |
| | Title: | Chief Financial Officer |
Date: August 7, 2025
